This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Shanghai Yuyao Biotech Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Xiufeng Pang in Pharmaceutical Chemistry
Introduction
Xiufeng Pang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on targeting specific phosphorylation sites in proteins, which is crucial for the treatment of various diseases.
Latest Patents
Xiufeng Pang holds a patent for a class of triaromatic compounds that target a bifunctional phosphorylation site of STAT3. The patent, which is represented by formulas (I) to (V), includes pharmaceutically acceptable salts, hydrates, solvates, metabolites, or prodrugs thereof. The proposed pharmaceutical compositions are aimed at preventing and treating diseases caused or regulated by the activation of this phosphorylation site.
Career Highlights
Pang is associated with Shanghai Yuyao Biotech Ltd., where he continues to innovate in the field of drug development. His research has the potential to lead to significant advancements in therapies for diseases linked to STAT3 activation.
Collaborations
Some of his notable coworkers include Yihua Chen and Wenbo Zhou, who contribute to the collaborative efforts in research and development at Shanghai Yuyao Biotech Ltd.
Conclusion
Xiufeng Pang's work exemplifies the intersection of innovation and pharmaceutical science, showcasing the importance of targeted therapies in modern medicine. His contributions are paving the way for new treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile